1000+ Infants and Children
Daily Feeding, 1 Year
After one year of daily feeding of a multiprotein blend (the prototype for SpoonfulONE), participants showed a shift towards a less allergy-prone immune profile. This was indicated by a greater increase in the average levels of specific IgG4 relative to baseline compared with the control group and single or dual protein groups . Higher IgG4 levels are associated with potential protection from the effects of IgE and are therefore considered anti-allergenic.
*Data on file. Reaction rate estimated based on parent and physician events provided by the company. Mild reaction is categorized by itchiness, hives, vomiting, or diarrhea.
705 infants were fed SpoonfulONE daily for one month. Of 8,803 ingestions, both SpoonfulONE and Placebo had similar reaction rates. No cases of anaphylaxis were reported. Reported symptoms were mild, such as rash, diarrhea, and spit-up.See The Research